The primary objective of this clinical trial is to determine whether a new extensively hydrolyzed infant formula is hypoallergenic.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
New hydrolyzed formula
Commercially available hydrolyzed infant formula
Little Rock Allergy & Asthma
Little Rock, Arkansas, United States
Pediatric Care Medical Group, Inc
Huntington Beach, California, United States
Allergy Medical Group of the North Area
Hypoallergenicity
To demonstrate that the test formula does not provoke allergenic activity
Time frame: 14 Days
Digestive Tolerance
Time frame: 1 Week
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Roseville, California, United States
Brookstone Clinical Research Center
Columbus, Georgia, United States
Aeroallergy Research Labs of Savannah
Savannah, Georgia, United States
Idaho Allergy and Asthma Specialists
Eagle, Idaho, United States
Deaconness Clinic
Evansville, Indiana, United States
Anderson & Collins Clinical Research
Edison, New Jersey, United States
Mount Sinai Faculty Practice Associates Pediatric Allergy
New York, New York, United States
ENT & Allergy Associates
Newburgh, New York, United States
...and 4 more locations